VNDA logo
VNDA NASDAQ US

Vanda Pharmaceuticals Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Apr 2006
$7.00
▼ $-0.07 (-0.99%)
Vol 920K
5
Quality Score
fail
Mkt Cap
$521.2M
ROE
-16.8%
Margin
-39.7%
D/E
1.11
Beta
0.69
52W
$4–$7

Wall Street Consensus

11 analysts · Apr 2026
2
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
81.8%
Buy Rating

Price Chart

Similar Stocks

RGNX
Regenxbio Inc
$729.0M
ALT
Altimmune Inc
$376.7M
LXEO
Lexeo Therapeutics Inc
$724.8M
AURA
Aura Biosciences Inc
$346.1M
AVTX
Avalo Therapeutics Inc
$329.3M
STRO
Sutro Biopharma Inc
$98.6M
RCKT
Rocket Pharmaceuticals Inc
$379.9M

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-1.35 $-0.46 +$0.89
Sep 2025 $-0.46 $-0.38 +$0.08
Jun 2025 $-0.36 $-0.46 $-0.10
Mar 2025 $-0.61 $-0.50 +$0.11

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -12.9% -12.9% -12.9% -16.8% -16.8% -16.8%
P/E (TTM) — — — — — —
Net Margin -51.7% -32.9% -32.9% -39.7% -39.7% -39.7%
Gross Margin 94.8% 94.4% 94.4% 94.4% 94.4% 94.4%
D/E Ratio 1.09 1.09 1.09 1.11 1.11 1.11
Current Ratio 3.25 3.25 3.25 3.12 3.12 3.12

Key Ratios

ROA (TTM)
-13.4%
P/S (TTM)
2.46
P/B
0.5
EPS (TTM)
$-1.43
CF/Share
$0.25
Rev Growth 3Y
-9.6%
52W High
$7.25
52W Low
$3.81
$3.81 52-Week Range $7.25

How does VNDA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

VNDA AAPG ABEO ABOS ABP

VNDA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.5
▼ 81% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.5
▼ 79% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

VNDA profitability vs Biotechnology peers

ROE
-16.8%
▲ 75% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-39.7%
▲ 86% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
94.4%
▲ 20% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-13.4%
▲ 71% above peers (-46.7%)
vs Peers
vs Industry
Top tier

VNDA financial health vs Biotechnology peers

D/E ratio
1.1
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
3.1
▼ 30% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
▼ 29% below peers (1.0)
vs Peers
vs Industry
More volatile

VNDA fundamentals radar

VNDA Peer median Industry

VNDA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

VNDA vs peers: key metrics

Latest News

No related news yet